Cell-secreted matrices perpetuate the bone-forming phenotype of differentiated mesenchymal stem cells

Allison I. Hoch, Vaishali Mittal, Debika Mitra, Nina Vollmer, Christopher A. Zikry, Jonathan K Leach

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Prior to transplantation, mesenchymal stem/stromal cells (MSCs) can be induced toward the osteoblastic phenotype using a cocktail of soluble supplements. However, there is little evidence of differentiated MSCs directly participating in bone formation, suggesting that MSCs may either die or revert in phenotype upon transplantation. Cell-secreted decellularized extracellular matrices (DMs) are a promising platform to confer bioactivity and direct cell fate through the presentation of a complex and physiologically relevant milieu. Therefore, we examined the capacity of biomimetic DMs to preserve the mineral-producing phenotype upon withdrawal of the induction stimulus. Regardless of induction duration, ranging up to 6 weeks, MSCs exhibited up to a 5-fold reduction in osteogenic markers within 24 h following stimulus withdrawal. We show that seeding osteogenically induced MSCs on DMs yields up to 2-fold more calcium deposition than tissue culture plastic, and this improvement is at least partially mediated by increasing actin cytoskeletal tension via the ROCK II pathway. MSCs on DMs also secreted 25% more vascular endothelial growth factor (VEGF), a crucial endogenous proangiogenic factor that is abrogated during MSC osteogenic differentiation. The deployment of DMs into a subcutaneous ectopic site enhanced the persistence of MSCs 5-fold, vessel density 3-fold, and bone formation 2-fold more than MSCs delivered without DMs. These results underscore the need for deploying MSCs using biomaterial platforms such as DMs to preserve the in vitro-acquired mineral-producing phenotype and accelerate the process of bone repair.

Original languageEnglish (US)
Pages (from-to)178-187
Number of pages10
JournalBiomaterials
Volume74
DOIs
StatePublished - Jan 1 2016

Fingerprint

Bone Matrix
Stem cells
Mesenchymal Stromal Cells
Bone
Phenotype
Minerals
Tissue culture
Biomimetics
Biocompatible Materials
Bioactivity
Osteogenesis
Biomaterials
Vascular Endothelial Growth Factor A
Actins
Calcium
Repair
Transplantation
Plastics

Keywords

  • Bone
  • Dedifferentiation
  • Extracellular matrix
  • Mesenchymal stem/stromal cells
  • Osteogenesis

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Cell-secreted matrices perpetuate the bone-forming phenotype of differentiated mesenchymal stem cells. / Hoch, Allison I.; Mittal, Vaishali; Mitra, Debika; Vollmer, Nina; Zikry, Christopher A.; Leach, Jonathan K.

In: Biomaterials, Vol. 74, 01.01.2016, p. 178-187.

Research output: Contribution to journalArticle

Hoch, Allison I. ; Mittal, Vaishali ; Mitra, Debika ; Vollmer, Nina ; Zikry, Christopher A. ; Leach, Jonathan K. / Cell-secreted matrices perpetuate the bone-forming phenotype of differentiated mesenchymal stem cells. In: Biomaterials. 2016 ; Vol. 74. pp. 178-187.
@article{d50ad16919814a52b9130443bf6668e0,
title = "Cell-secreted matrices perpetuate the bone-forming phenotype of differentiated mesenchymal stem cells",
abstract = "Prior to transplantation, mesenchymal stem/stromal cells (MSCs) can be induced toward the osteoblastic phenotype using a cocktail of soluble supplements. However, there is little evidence of differentiated MSCs directly participating in bone formation, suggesting that MSCs may either die or revert in phenotype upon transplantation. Cell-secreted decellularized extracellular matrices (DMs) are a promising platform to confer bioactivity and direct cell fate through the presentation of a complex and physiologically relevant milieu. Therefore, we examined the capacity of biomimetic DMs to preserve the mineral-producing phenotype upon withdrawal of the induction stimulus. Regardless of induction duration, ranging up to 6 weeks, MSCs exhibited up to a 5-fold reduction in osteogenic markers within 24 h following stimulus withdrawal. We show that seeding osteogenically induced MSCs on DMs yields up to 2-fold more calcium deposition than tissue culture plastic, and this improvement is at least partially mediated by increasing actin cytoskeletal tension via the ROCK II pathway. MSCs on DMs also secreted 25{\%} more vascular endothelial growth factor (VEGF), a crucial endogenous proangiogenic factor that is abrogated during MSC osteogenic differentiation. The deployment of DMs into a subcutaneous ectopic site enhanced the persistence of MSCs 5-fold, vessel density 3-fold, and bone formation 2-fold more than MSCs delivered without DMs. These results underscore the need for deploying MSCs using biomaterial platforms such as DMs to preserve the in vitro-acquired mineral-producing phenotype and accelerate the process of bone repair.",
keywords = "Bone, Dedifferentiation, Extracellular matrix, Mesenchymal stem/stromal cells, Osteogenesis",
author = "Hoch, {Allison I.} and Vaishali Mittal and Debika Mitra and Nina Vollmer and Zikry, {Christopher A.} and Leach, {Jonathan K}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2015.10.003",
language = "English (US)",
volume = "74",
pages = "178--187",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Cell-secreted matrices perpetuate the bone-forming phenotype of differentiated mesenchymal stem cells

AU - Hoch, Allison I.

AU - Mittal, Vaishali

AU - Mitra, Debika

AU - Vollmer, Nina

AU - Zikry, Christopher A.

AU - Leach, Jonathan K

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Prior to transplantation, mesenchymal stem/stromal cells (MSCs) can be induced toward the osteoblastic phenotype using a cocktail of soluble supplements. However, there is little evidence of differentiated MSCs directly participating in bone formation, suggesting that MSCs may either die or revert in phenotype upon transplantation. Cell-secreted decellularized extracellular matrices (DMs) are a promising platform to confer bioactivity and direct cell fate through the presentation of a complex and physiologically relevant milieu. Therefore, we examined the capacity of biomimetic DMs to preserve the mineral-producing phenotype upon withdrawal of the induction stimulus. Regardless of induction duration, ranging up to 6 weeks, MSCs exhibited up to a 5-fold reduction in osteogenic markers within 24 h following stimulus withdrawal. We show that seeding osteogenically induced MSCs on DMs yields up to 2-fold more calcium deposition than tissue culture plastic, and this improvement is at least partially mediated by increasing actin cytoskeletal tension via the ROCK II pathway. MSCs on DMs also secreted 25% more vascular endothelial growth factor (VEGF), a crucial endogenous proangiogenic factor that is abrogated during MSC osteogenic differentiation. The deployment of DMs into a subcutaneous ectopic site enhanced the persistence of MSCs 5-fold, vessel density 3-fold, and bone formation 2-fold more than MSCs delivered without DMs. These results underscore the need for deploying MSCs using biomaterial platforms such as DMs to preserve the in vitro-acquired mineral-producing phenotype and accelerate the process of bone repair.

AB - Prior to transplantation, mesenchymal stem/stromal cells (MSCs) can be induced toward the osteoblastic phenotype using a cocktail of soluble supplements. However, there is little evidence of differentiated MSCs directly participating in bone formation, suggesting that MSCs may either die or revert in phenotype upon transplantation. Cell-secreted decellularized extracellular matrices (DMs) are a promising platform to confer bioactivity and direct cell fate through the presentation of a complex and physiologically relevant milieu. Therefore, we examined the capacity of biomimetic DMs to preserve the mineral-producing phenotype upon withdrawal of the induction stimulus. Regardless of induction duration, ranging up to 6 weeks, MSCs exhibited up to a 5-fold reduction in osteogenic markers within 24 h following stimulus withdrawal. We show that seeding osteogenically induced MSCs on DMs yields up to 2-fold more calcium deposition than tissue culture plastic, and this improvement is at least partially mediated by increasing actin cytoskeletal tension via the ROCK II pathway. MSCs on DMs also secreted 25% more vascular endothelial growth factor (VEGF), a crucial endogenous proangiogenic factor that is abrogated during MSC osteogenic differentiation. The deployment of DMs into a subcutaneous ectopic site enhanced the persistence of MSCs 5-fold, vessel density 3-fold, and bone formation 2-fold more than MSCs delivered without DMs. These results underscore the need for deploying MSCs using biomaterial platforms such as DMs to preserve the in vitro-acquired mineral-producing phenotype and accelerate the process of bone repair.

KW - Bone

KW - Dedifferentiation

KW - Extracellular matrix

KW - Mesenchymal stem/stromal cells

KW - Osteogenesis

UR - http://www.scopus.com/inward/record.url?scp=84945156157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945156157&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2015.10.003

DO - 10.1016/j.biomaterials.2015.10.003

M3 - Article

VL - 74

SP - 178

EP - 187

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -